A new study has affirmed the anesthetic drug xenon can help prevent long-term damage associated with traumatic brain injury (TBI). The researchers, from Imperial College London and Johannes Gutenberg University Mainz, have effectively demonstrated in mice that if xenon is administered within a few hours of a TBI it can prevent brain tissue damage that would result in long-term cognitive problems.

In a new study from the University of Illinois at Chicago, researchers examining post-mortem brain tissue from people ages 79 to 99 found that new neurons continue to form well into old age. The study provides evidence that this occurs even in people with cognitive impairment and Alzheimer’s disease, although neurogenesis is significantly reduced in these people compared to older adults with normal cognitive functioning.

They publish their results in the journal Cell Stem Cell.

The idea that new neurons continue to form into middle age, let alone past adolescence, is controversial, as previous studies have shown conflicting results. The UIC study is the first to find evidence of significant numbers of neural stem cells and newly developing neurons present in the hippocampal tissue of older adults, including those with disorders that affect the hippocampus, which is involved in the formation of memories and in learning.

The electronic Barnett effect, first observed by Samuel Barnett in 1915, is the magnetization of an uncharged body as it is spun on its long axis. This is caused by a coupling between the angular momentum of the electronic spins and the rotation of the rod.

Using a different method from that employed by Barnett, two researchers at NYU observed an alternative version of this effect called the nuclear Barnett effect, which results from the magnetization of protons rather than electrons. Their study, published in Physical Review Letters (PRL), led to the first experimental observation of this effect.

“I was a graduate student at NYU where a group of colleagues were involved in a project related to brain imaging,” Mohsen Arabgol, one of the researchers who carried out the study, told Phys.org. The fundamental idea behind the project was polarizing the brain molecules by inducing rotation using the Barnett effect and then applying the MRI-type imaging. I became interested and decided to work on the detection of the nuclear Barnett effect as my Ph.D. dissertation.”

People who suffer a stroke caused by bleeding in the brain—known as brain haemorrhage—can take common medicines without raising their risk of another stroke, a major clinical trial has found.

Researchers say the findings are reassuring for the thousands of people who take the medicines to reduce their risk of heart attack and another common type of stroke caused by blood clots in the brain.

These everyday treatments—known as antiplatelet medicines—work by slowing or stopping blood from clotting. They are often prescribed to older people because they can lower risk of heart attack and stroke caused by a blood clot.